Galmed Pharmaceuticals (GLMD) Receivables - Net (2013 - 2024)

Galmed Pharmaceuticals' Receivables - Net history runs 10 years deep, the most recent figure standing at $672000.0 for Q4 2024.

• In Q4 2024, Receivables - Net rose 40.0% year-over-year to $672000.0; the TTM figure through Dec 2024 stood at $672000.0 (up 40.0% YoY), while the FY2024 annual figure was $672000.0, up 40.0% from the prior year.
• Receivables - Net was $672000.0 for Q4 2024 at Galmed Pharmaceuticals, up from $480000.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $1.1 million in Q4 2021 to a low of $480000.0 in Q4 2023.
• Historically, Receivables - Net has averaged $782800.0 across 5 years, with a median of $812000.0 in 2020.
• The sharpest annual moves came in 2023 and 2024: Receivables - Net slumped 41.82% in 2023, then jumped 40.0% in 2024.
• A 5-year view of Receivables - Net shows it stood at $812000.0 in 2020, then soared by 38.55% to $1.1 million in 2021, then retreated by 26.67% to $825000.0 in 2022, then tumbled by 41.82% to $480000.0 in 2023, then surged by 40.0% to $672000.0 in 2024.
• The last three Receivables - Net figures came in at $672000.0 (Q4 2024), $480000.0 (Q4 2023), and $825000.0 (Q4 2022), per Business Quant data.